Product Information
SYMLINPEN 120 PEN INJECTOR is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $217.5214 per ML under NDC 00310662702. Its NADAC has been published 334 times since Mar 18, 2015.
Strength
1000 ug/mL
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310662702
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/18/2025
Active Ingredients
PRAMLINTIDE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA021332On Market Since
1/8/2015
Pharmacological Classes
Price Statistics
The NADAC for SYMLINPEN 120 PEN INJECTOR has been published 334 times since Mar 18, 2015, and over the history we have for it it has risen 74.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $217.5214 per ML |
|---|---|
| All-time high | $217.7933 (Dec 11, 2024) |
| All-time low | $124.9109 (Mar 18, 2015) |
| 52-week high | $217.5214 |
| 52-week low | $217.5214 |
| Median price | $188.5170 |
| Average price | $182.1335 |
| Largest weekly change | +17.0% (Jan 13, 2016) |
| Weeks tracked | 334 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYMLINPEN 120 PEN INJECTOR?
The current National Average Drug Acquisition Cost (NADAC) for SYMLINPEN 120 PEN INJECTOR, manufactured by AstraZeneca Pharmaceuticals LP, is $217.5214 per ML (NDC 00310662702), effective Jun 10, 2026.
How has the price of SYMLINPEN 120 PEN INJECTOR changed over time?
Over the history we have for it, the NADAC for SYMLINPEN 120 PEN INJECTOR has risen 74.1%. It has been tracked across 334 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for SYMLINPEN 120 PEN INJECTOR?
Since Mar 18, 2015, the NADAC for SYMLINPEN 120 PEN INJECTOR has ranged from a low of $124.9109 (Mar 18, 2015) to a high of $217.7933 (Dec 11, 2024), with a median of $188.5170 per ML.
Are there cheaper alternatives to SYMLINPEN 120 PEN INJECTOR?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SYMLINPEN 120 PEN INJECTOR, but none are currently priced below it.
Who manufactures SYMLINPEN 120 PEN INJECTOR?
SYMLINPEN 120 PEN INJECTOR (NDC 00310662702) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.
Related Drugs
Same classification